NBC Securities Inc. Purchases 8,352 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH)

NBC Securities Inc. grew its stake in U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 104,400.0% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 8,360 shares of the company's stock after purchasing an additional 8,352 shares during the quarter. NBC Securities Inc. owned about 0.06% of U.S. Physical Therapy worth $604,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in the stock. Vanguard Group Inc. raised its holdings in U.S. Physical Therapy by 0.6% in the 4th quarter. Vanguard Group Inc. now owns 1,084,197 shares of the company's stock worth $96,179,000 after purchasing an additional 6,393 shares in the last quarter. Southernsun Asset Management LLC grew its position in shares of U.S. Physical Therapy by 4.5% in the 4th quarter. Southernsun Asset Management LLC now owns 571,809 shares of the company's stock worth $50,725,000 after buying an additional 24,698 shares during the period. Dimensional Fund Advisors LP grew its position in shares of U.S. Physical Therapy by 1.9% in the 4th quarter. Dimensional Fund Advisors LP now owns 426,298 shares of the company's stock worth $37,818,000 after buying an additional 7,890 shares during the period. Envestnet Asset Management Inc. grew its position in shares of U.S. Physical Therapy by 20.1% in the 4th quarter. Envestnet Asset Management Inc. now owns 299,791 shares of the company's stock worth $26,594,000 after buying an additional 50,163 shares during the period. Finally, Northern Trust Corp grew its position in shares of U.S. Physical Therapy by 13.9% in the 4th quarter. Northern Trust Corp now owns 261,825 shares of the company's stock worth $23,226,000 after buying an additional 32,024 shares during the period.

U.S. Physical Therapy Stock Up 1.9%

USPH stock traded up $1.47 during trading on Friday, hitting $77.27. 171,979 shares of the stock traded hands, compared to its average volume of 113,547. U.S. Physical Therapy, Inc. has a 1 year low of $62.77 and a 1 year high of $101.20. The firm's 50 day moving average is $72.29 and its two-hundred day moving average is $81.99. The stock has a market cap of $1.17 billion, a price-to-earnings ratio of 82.21, a price-to-earnings-growth ratio of 3.54 and a beta of 1.45. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.78 and a quick ratio of 1.78.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last announced its quarterly earnings data on Wednesday, May 7th. The company reported $0.48 EPS for the quarter, beating the consensus estimate of $0.46 by $0.02. U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%. The company had revenue of $183.79 million for the quarter, compared to the consensus estimate of $176.78 million. During the same period in the prior year, the firm posted $0.51 EPS. U.S. Physical Therapy's revenue for the quarter was up 18.0% on a year-over-year basis. On average, sell-side analysts anticipate that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current year.

U.S. Physical Therapy Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, June 13th. Stockholders of record on Friday, May 23rd will be issued a dividend of $0.45 per share. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.33%. The ex-dividend date of this dividend is Friday, May 23rd. U.S. Physical Therapy's payout ratio is presently 82.57%.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on USPH shares. Barrington Research reduced their target price on shares of U.S. Physical Therapy from $108.00 to $98.00 and set an "outperform" rating on the stock in a research report on Friday, February 28th. William Blair reaffirmed a "market perform" rating on shares of U.S. Physical Therapy in a research report on Thursday, February 27th. JPMorgan Chase & Co. reduced their target price on shares of U.S. Physical Therapy from $120.00 to $110.00 and set an "overweight" rating on the stock in a research report on Wednesday, March 19th. JMP Securities reaffirmed a "market outperform" rating and issued a $113.00 target price on shares of U.S. Physical Therapy in a research report on Tuesday, April 22nd. Finally, Wall Street Zen raised shares of U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research report on Thursday, May 8th. Two research analysts have rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, U.S. Physical Therapy currently has a consensus rating of "Moderate Buy" and an average price target of $109.00.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.